CD8A and cancer: In addition to observational studies, investigations into cancer cells, hosts, and microenvironments have postulated mechanisms through which cancerous cells are eliminated efficiently by CD8+ cells, although Tregs weaken cellular immune response by impeding the activation of effector T cells, preventing cancer cells from being destroyed and promoting tumor growth (2, 3, 44).